EE200000214A - Ravimid - Google Patents

Ravimid

Info

Publication number
EE200000214A
EE200000214A EEP200000214A EEP200000214A EE200000214A EE 200000214 A EE200000214 A EE 200000214A EE P200000214 A EEP200000214 A EE P200000214A EE P200000214 A EEP200000214 A EE P200000214A EE 200000214 A EE200000214 A EE 200000214A
Authority
EE
Estonia
Prior art keywords
medications
Prior art date
Application number
EEP200000214A
Other languages
English (en)
Estonian (et)
Inventor
Wayne Mangel Allen
Ruth Northcutt Allison
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10820099&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200000214(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of EE200000214A publication Critical patent/EE200000214A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EEP200000214A 1997-10-07 1998-10-05 Ravimid EE200000214A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9721139.5A GB9721139D0 (en) 1997-10-07 1997-10-07 Medicaments
PCT/EP1998/006278 WO1999017755A2 (en) 1997-10-07 1998-10-05 Medicaments

Publications (1)

Publication Number Publication Date
EE200000214A true EE200000214A (et) 2001-06-15

Family

ID=10820099

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000214A EE200000214A (et) 1997-10-07 1998-10-05 Ravimid

Country Status (36)

Country Link
US (3) US6284770B1 (id)
EP (1) EP1021174A2 (id)
JP (1) JP2001518495A (id)
KR (1) KR20010015707A (id)
CN (1) CN1281357A (id)
AP (1) AP2000001785A0 (id)
AR (1) AR017296A1 (id)
AU (1) AU750818B2 (id)
BR (1) BR9812886A (id)
CA (1) CA2305751A1 (id)
CO (1) CO5011096A1 (id)
DZ (1) DZ2618A1 (id)
EA (1) EA003184B1 (id)
EE (1) EE200000214A (id)
GB (1) GB9721139D0 (id)
GT (1) GT199800157A (id)
HN (1) HN1998000155A (id)
HR (1) HRP20000198A2 (id)
HU (1) HUP0003750A3 (id)
ID (1) ID23874A (id)
IL (1) IL135398A0 (id)
IS (1) IS5425A (id)
MA (1) MA26549A1 (id)
NO (1) NO20001776L (id)
NZ (1) NZ503698A (id)
PA (1) PA8461101A1 (id)
PE (1) PE120299A1 (id)
PL (1) PL340337A1 (id)
SK (1) SK4862000A3 (id)
SV (1) SV1998000122A (id)
TN (1) TNSN98179A1 (id)
TR (1) TR200000913T2 (id)
UY (1) UY25200A1 (id)
WO (1) WO1999017755A2 (id)
YU (1) YU20600A (id)
ZA (1) ZA989061B (id)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9721139D0 (en) 1997-10-07 1997-12-03 Glaxo Group Ltd Medicaments
US7767203B2 (en) * 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
US6136807A (en) * 1998-11-10 2000-10-24 3M Innovative Properties Company Composition for the transdermal delivery of lerisetron
EP1090638A1 (en) * 1999-10-08 2001-04-11 Sanofi-Synthelabo Use of (R)-zacopride or a salt thereof for the manufacture of a medicament for the treatment of sleep apnea
TWI263496B (en) * 1999-12-10 2006-10-11 Novartis Ag Pharmaceutical combinations and their use in treating gastrointestinal disorders
DE10015783C2 (de) * 2000-03-30 2003-12-04 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Abgabe von Lerisetron und seine Verwendung
JP2003533482A (ja) * 2000-05-18 2003-11-11 グラクソ グループ リミテッド 機能性消化不良の治療方法
US6566369B2 (en) 2000-07-26 2003-05-20 Solvay Pharmaceuticals Gmbh Medicament containing cilansetron for the treatment of non-obstipative male irritable bowel syndrome patients
AR028970A1 (es) * 2000-07-26 2003-05-28 Solvay Pharm Gmbh USO DE CILANSETRON O DE SUS SALES POR ADICIoN DE A CIDOS Y/O SOLVATOS FARMACOLoGICAMENTE COMPATIBLES PARA LA OBTENCIoN DE PREPARADOS FARMACEUTICOS PARA EL TRATAMIENTO Y/O LA PROFILAXIS DEL SíNDROME DEL INTESTINO IRRITABLE
EP1315837A2 (en) * 2000-09-06 2003-06-04 Glaxo Group Limited 5-hydroxytryptamine receptor gene polymorphisms and response to treatment
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
EP1395289B1 (en) * 2001-06-07 2010-12-15 Christine Dr. Sang Treatment of neuropathic pain with a n-methyl-d-aspartate (nmda) receptor antagonists
US7045549B2 (en) 2001-11-08 2006-05-16 The Board Of Trustees Of The Leland Stanford Jr. University Treatment of symptoms associated with irritable bowel syndrome
CA2473392A1 (en) * 2002-01-18 2003-07-31 Aryx Therapeutics 5-ht3 receptor antagonists and methods of use
WO2004004734A1 (en) * 2002-07-10 2004-01-15 Arachnova Therapeutics Ltd. 4-(2-fluorophenyl)-6-methyl-2(1-piperazinyl)thieno(2,3-d) pyrimidine in the treatment of functional bowel disorder
DE10232750A1 (de) * 2002-07-18 2004-02-05 Basf Ag Verfahren zur Herstellung von macrocyclischen Ketonen durch Dieckmann-Kondensation in der Gasphase
JP4399862B2 (ja) * 2002-08-09 2010-01-20 味の素株式会社 腸疾患および内臓痛の治療薬
US20030187017A1 (en) * 2002-11-14 2003-10-02 Mangel Allen Wayne Method for treating functional dyspepsia
JP2006516977A (ja) * 2003-01-13 2006-07-13 ダイノゲン ファーマシューティカルズ，インコーポレイテッド 悪心、嘔吐、レッチング、またはそれらの任意の組み合わせの治療方法
PL378367A1 (pl) * 2003-01-13 2006-04-03 Dynogen Pharmaceuticals, Inc. Sposób leczenia czynnościowych zaburzeń jelit
JO2735B1 (en) 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formulations of palonosetron
ZA200409537B (en) 2003-01-31 2006-10-25 Yamanouchi Pharma Co Ltd Stable solid medicinal composition for oral administration
WO2005058819A2 (en) * 2003-12-16 2005-06-30 Teva Pharmaceutical Industries Ltd. Polymorphic forms of tegaserod base and salts thereof
US7358270B2 (en) 2004-01-30 2008-04-15 Astellas Pharma Inc. Treating agent for irritable bowel syndrome
WO2005073220A1 (ja) * 2004-01-30 2005-08-11 Yamanouchi Pharmaceutical Co., Ltd. 下痢型過敏性腸症候群治療剤
CA2516433C (en) * 2004-01-30 2009-06-02 Astellas Pharma Inc. Ramosetron hydrochloride for diarrhea-predominant irritable bowel syndrome
JP3763360B2 (ja) * 2004-01-30 2006-04-05 アステラス製薬株式会社 下痢型過敏性腸症候群治療剤
AU2005213305A1 (en) * 2004-02-03 2005-08-25 Daniel Rachmilewitz Methods of treating irritable bowel syndrome
JP4559749B2 (ja) * 2004-02-16 2010-10-13 あすか製薬株式会社 ピペラジニルピリジン誘導体
US7799775B2 (en) 2004-02-26 2010-09-21 Aska Pharmaceutical Co., Ltd. Pyrimidine derivatives
JP2006028028A (ja) * 2004-07-12 2006-02-02 Teikoku Medix Kk 経口医薬組成物
US20060293309A1 (en) * 2005-03-28 2006-12-28 Dynogen Pharmaceuticals, Inc. Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
WO2006133104A2 (en) * 2005-06-07 2006-12-14 Theravance, Inc. Benzoimidazolone-carboxamide compounds as 5-ht4 receptor agonists
WO2007000046A1 (en) * 2005-06-27 2007-01-04 Holburn Biomedical Corporation Methods for diagnosing functional bowel disease
JP4632204B2 (ja) * 2005-09-21 2011-02-16 アステラス製薬株式会社 下痢型過敏性腸症候群治療剤
ZA200806983B (en) * 2006-02-20 2009-11-25 Astellas Pharma Inc Amide derivative or salt thereof
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators
WO2009053750A2 (en) 2007-10-24 2009-04-30 Generics [Uk] Limited Novel crystalline and amorphous forms
WO2009053754A2 (en) 2007-10-24 2009-04-30 Generics [Uk] Limited Novel crystalline forms
WO2009053732A1 (en) 2007-10-24 2009-04-30 Generics [Uk] Limited Novel salt
WO2009053733A2 (en) 2007-10-24 2009-04-30 Generics [Uk] Limited Novel crystalline forms
US8734867B2 (en) * 2007-12-28 2014-05-27 Liveleaf, Inc. Antibacterial having an extract of pomegranate combined with hydrogen peroxide
EP2403938B1 (en) 2009-03-04 2019-12-11 Liveleaf, Inc. Method and material for site activated complexing of biologic molecules
EP3246039A1 (en) 2009-04-29 2017-11-22 Ganeden Biotech, Inc. Bacterial cell membrane formulation
WO2011001954A1 (ja) * 2009-06-30 2011-01-06 アステラス製薬株式会社 緩解期の炎症性腸疾患患者における排便異常治療剤
JP5938886B2 (ja) * 2010-12-14 2016-06-22 アステラス製薬株式会社 活動期の炎症性腸疾患患者における排便異常治療剤
US8722040B2 (en) 2011-06-24 2014-05-13 Liveleaf, Inc. Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites
US9192635B2 (en) 2011-06-24 2015-11-24 Liveleaf, Inc. Method of treating damaged mucosal or gastrointestinal tissue by administering a composition comprising a mixture of pomegranate and green tea extracts and releasably bound hydrogen peroxide
US20120329736A1 (en) * 2011-06-24 2012-12-27 Huang Alexander L Treatment for gastrointestinal disorders using a selective, site-activated binding system
WO2013057554A2 (en) * 2011-10-18 2013-04-25 Helsinn Healthcare Sa Therapeutic combinations of netupitant and palonosetron
HK1210947A1 (en) 2012-09-05 2016-05-13 Chase Pharmaceuticals Corporation Anticholinergic neuroprotective composition and methods
US8716351B1 (en) 2012-12-23 2014-05-06 Liveleaf, Inc. Methods of treating gastrointestinal spasms

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0254584B1 (en) 1986-07-25 1992-10-07 Beecham Group Plc Azabicyclic compounds, process for their preparation, and their pharmaceutical use
GB8806990D0 (en) 1988-03-23 1988-04-27 Beecham Group Plc Novel compounds
GB8701022D0 (en) 1987-01-19 1987-02-18 Beecham Group Plc Treatment
GB2209335B (en) 1987-09-03 1991-05-29 Glaxo Group Ltd Lactam derivatives
ATE108791T1 (de) * 1987-11-04 1994-08-15 Beecham Group Plc Neue 4-oxobenzotriazine und 4-oxochinazoline.
EP0336759A1 (en) 1988-04-07 1989-10-11 Glaxo Group Limited Imidazole derivatives
GB8814277D0 (en) 1988-06-16 1988-07-20 Glaxo Group Ltd Chemical compounds
US5017573A (en) * 1988-07-29 1991-05-21 Dainippon Pharmaceutical Co., Ltd. Indazole-3-carboxylic acid derivatives
GB8820650D0 (en) 1988-09-01 1988-10-05 Glaxo Group Ltd Medicaments
GB8823980D0 (en) 1988-10-13 1988-11-23 Glaxo Group Ltd Chemical compounds
GB8829079D0 (en) * 1988-12-13 1989-01-25 Beecham Group Plc Novel compounds
GB8904551D0 (en) * 1989-02-28 1989-04-12 Glaxo Group Ltd Chemical compounds
EP0387431A1 (en) 1989-03-14 1990-09-19 Beecham Group Plc Imidazole derivatives, process for their preparation and their pharmaceutical use
GB9020927D0 (en) 1990-09-26 1990-11-07 Beecham Group Plc Pharmaceuticals
GB9027098D0 (en) * 1990-12-13 1991-02-06 Beecham Group Plc Pharmaceuticals
GB9027487D0 (en) 1990-12-19 1991-02-06 Beecham Group Plc Pharmaceuticals
AU1161292A (en) * 1991-01-09 1992-08-17 Smithkline Beecham Plc Azabicydic and azatricydic derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them
GB9214184D0 (en) 1992-07-03 1992-08-12 Smithkline Beecham Plc Pharmaceuticals
GB9721139D0 (en) * 1997-10-07 1997-12-03 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
EA200000299A1 (ru) 2000-12-25
US20010044450A1 (en) 2001-11-22
US6284770B1 (en) 2001-09-04
DZ2618A1 (fr) 2003-03-01
MA26549A1 (fr) 2004-12-20
EA003184B1 (ru) 2003-02-27
NZ503698A (en) 2002-10-25
AP2000001785A0 (en) 2000-06-30
WO1999017755A3 (en) 1999-09-23
WO1999017755A2 (en) 1999-04-15
CO5011096A1 (es) 2001-02-28
HUP0003750A3 (en) 2003-02-28
PE120299A1 (es) 1999-12-15
AU9629398A (en) 1999-04-27
HUP0003750A2 (hu) 2001-10-28
AU750818B2 (en) 2002-07-25
JP2001518495A (ja) 2001-10-16
AR017296A1 (es) 2001-09-05
YU20600A (sh) 2003-10-31
GT199800157A (es) 2000-03-30
EP1021174A2 (en) 2000-07-26
TR200000913T2 (tr) 2001-01-22
TNSN98179A1 (fr) 2005-03-15
NO20001776L (no) 2000-06-06
ZA989061B (en) 2001-07-05
IS5425A (is) 2000-03-31
KR20010015707A (ko) 2001-02-26
HRP20000198A2 (en) 2001-04-30
BR9812886A (pt) 2000-08-08
HN1998000155A (es) 1999-05-24
US6429209B2 (en) 2002-08-06
NO20001776D0 (no) 2000-04-06
PL340337A1 (en) 2001-01-29
US6593336B2 (en) 2003-07-15
UY25200A1 (es) 2001-01-31
CN1281357A (zh) 2001-01-24
IL135398A0 (en) 2001-05-20
CA2305751A1 (en) 1999-04-15
SK4862000A3 (en) 2001-01-18
PA8461101A1 (es) 2000-05-24
GB9721139D0 (en) 1997-12-03
ID23874A (id) 2000-05-25
SV1998000122A (es) 1999-07-05
US20030036549A1 (en) 2003-02-20

Similar Documents

Publication Publication Date Title
EE200000214A (et) Ravimid
ATA93198A (de) Fluoxetinpellets
DE69816767D1 (de) Polklemme
DK1017392T3 (da) Lægemiddel
DE59803185D1 (de) Baulaser
ATA111897A (de) Kimme
DE59802506D1 (de) Weichspülmittelzusammemsetzung
DE59804631D1 (de) Diketopyrrolopyrrolzusammensetzungen
DE59804377D1 (de) Kryoventil
DE59801498D1 (de) Dioxacycloalkan-8-one
ATE236897T1 (de) 3-benzylpiperidine
ATA112597A (de) Snowboard - bindung
DE59805053D1 (de) Bogenflexodruckmaschine
ATA46498A (de) Kunststoffgleitbahn
ATA86797A (de) Verschleissschuh
FR2772264B1 (fr) Pilulier
BR9701194A (pt) Hidrociclo
UA25523A (uk) Лікувальhий препарат гірчичhик
FI3092U1 (fi) Lompakko matkapuhelinkotelo
ATE421585T1 (de) Motlinhomologe
DE59804542D1 (de) Arylaminomethylencampherderivate
ITDP970013A1 (it) Ruota singola - attrezzo sportivo - cicloidi
BR7702867U (pt) Negatoscópio
BR9700388A (pt) Fura-fura-areia-aspiral
BR9700394A (pt) Triolim